The University of Chicago Header Logo

Connection

Tammy Utset to Recombinant Fusion Proteins

Back to Details
This is a "connection" page, showing publications Tammy Utset has written about Recombinant Fusion Proteins.
Tammy Utset
Connection Strength
0.142
Recombinant Fusion Proteins
  1. Clinical Efficacy and Safety of Baminercept, a Lymphotoxin ß Receptor Fusion Protein, in Primary Sjögren's Syndrome: Results From a Phase II Randomized, Double-Blind, Placebo-Controlled Trial. Arthritis Rheumatol. 2018 09; 70(9):1470-1480.
    View in: PubMed
    Score: 0.142
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.